Novartis invested EUR 204m in Slovenia in 2020

Ljubljana – The Swiss pharma giant Novartis continued to invest in its R&D and production capacities in Slovenia through its subsidiaries Lek, Sandoz and Novartis Pharma Services last year. Despite the Covid-19 epidemic, it invested EUR 204 million in the country, show figures presented on Tuesday. The company said this marked the continuation of its efforts to expand its R&D and production facilities in line with its plan to transform from a generics to an innovative pharmaceutical company. In the last 17 years, Novartis has invested more than EUR 2.7…

For FREE further reading please JUST enter your email address

I allow to collect my email data for analytics and email campaign